Foster & Motley’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23M | Buy |
17,101
+514
| +3% | +$39.6K | 0.06% | 209 |
|
|
2025
Q4 | $1.32M | Sell |
16,587
-2,444
| -13% | -$193K | 0.07% | 205 |
|
|
2025
Q3 | $1.44M | Sell |
19,031
-3,845
| -17% | -$264K | 0.08% | 196 |
|
|
2025
Q2 | $1.58M | Sell |
22,876
-1,491
| -6% | -$97.8K | 0.09% | 190 |
|
|
2025
Q1 | $1.65M | Sell |
24,367
-3,920
| -14% | -$235K | 0.1% | 173 |
|
|
2024
Q4 | $1.27M | Sell |
28,287
-7,740
| -21% | -$434K | 0.08% | 196 |
|
|
2024
Q3 | $2.27M | Sell |
36,027
-12,110
| -25% | -$707K | 0.14% | 139 |
|
|
2024
Q2 | $2.84M | Sell |
48,137
-6,764
| -12% | -$423K | 0.2% | 121 |
|
|
2024
Q1 | $4.38M | Sell |
54,901
-7,210
| -12% | -$551K | 0.3% | 94 |
|
|
2023
Q4 | $4.9M | Sell |
62,111
-3,167
| -5% | -$225K | 0.36% | 78 |
|
|
2023
Q3 | $4.56M | Sell |
65,278
-7,173
| -10% | -$508K | 0.37% | 81 |
|
|
2023
Q2 | $5.01M | Sell |
72,451
-6,954
| -9% | -$495K | 0.39% | 69 |
|
|
2023
Q1 | $5.9M | Buy |
79,405
+6,757
| +9% | +$567K | 0.48% | 51 |
|
|
2022
Q4 | $6.77M | Buy |
72,648
+2,197
| +3% | +$212K | 0.58% | 41 |
|
|
2022
Q3 | $6.72M | Buy |
70,451
+3,334
| +5% | +$330K | 0.64% | 36 |
|
|
2022
Q2 | $6.22M | Buy |
67,117
+3,470
| +5% | +$339K | 0.55% | 39 |
|
|
2022
Q1 | $6.44M | Buy |
63,647
+3,165
| +5% | +$332K | 0.51% | 45 |
|
|
2021
Q4 | $6.24M | Buy |
60,482
+2,813
| +5% | +$260K | 0.49% | 54 |
|
|
2021
Q3 | $4.89M | Buy |
57,669
+4,914
| +9% | +$412K | 0.41% | 61 |
|
|
2021
Q2 | $4.4M | Buy |
52,755
+3,765
| +8% | +$308K | 0.37% | 69 |
|
|
2021
Q1 | $3.69M | Buy |
48,990
+1,762
| +4% | +$128K | 0.31% | 78 |
|
|
2020
Q4 | $3.23M | Buy |
47,228
+6,402
| +16% | +$416K | 0.31% | 81 |
|
|
2020
Q3 | $2.38M | Buy |
40,826
+1,737
| +4% | +$108K | 0.28% | 97 |
|
|
2020
Q2 | $2.54M | Buy |
39,089
+3,599
| +10% | +$227K | 0.32% | 91 |
|
|
2020
Q1 | $2.11M | Buy |
35,490
+1,954
| +6% | +$130K | 0.31% | 93 |
|
|
2019
Q4 | $2.49M | Sell |
33,536
-8,095
| -19% | -$568K | 0.31% | 92 |
|
|
2019
Q3 | $2.63M | Sell |
41,631
-1,930
| -4% | -$114K | 0.36% | 82 |
|
|
2019
Q2 | $2.37M | Sell |
43,561
-8,226
| -16% | -$443K | 0.33% | 89 |
|
|
2019
Q1 | $2.79M | Sell |
51,787
-225
| -0.4% | -$13.9K | 0.4% | 72 |
|
|
2018
Q4 | $3.41M | Buy |
52,012
+10,369
| +25% | +$774K | 0.55% | 51 |
|
|
2018
Q3 | $3.28M | Sell |
41,643
-3,980
| -9% | -$285K | 0.49% | 64 |
|
|
2018
Q2 | $2.94M | Buy |
45,623
+9,031
| +25% | +$595K | 0.47% | 65 |
|
|
2018
Q1 | $2.28M | Buy |
36,592
+9,183
| +34% | +$659K | 0.37% | 80 |
|
|
2017
Q4 | $1.99M | Buy |
27,409
+7,066
| +35% | +$514K | 0.32% | 87 |
|
|
2017
Q3 | $1.65M | Buy |
20,343
+6,855
| +51% | +$542K | 0.28% | 93 |
|
|
2017
Q2 | $1.08M | Buy |
13,488
+925
| +7% | +$73K | 0.19% | 101 |
|
|
2017
Q1 | $986K | Buy |
12,563
+6,696
| +114% | +$535K | 0.18% | 108 |
|
|
2016
Q4 | $463K | Buy |
5,867
+2,413
| +70% | +$195K | 0.09% | 135 |
|
|
2016
Q3 | $307K | Buy |
3,454
+263
| +8% | +$24.8K | 0.06% | 150 |
|
|
2016
Q2 | $306K | Buy |
3,191
+125
| +4% | +$12.5K | 0.06% | 145 |
|
|
2016
Q1 | $318K | Buy |
3,066
+353
| +13% | +$34.3K | 0.06% | 145 |
|
|
2015
Q4 | $265K | Buy |
+2,713
| New | +$266K | 0.06% | 161 |
|
|
2015
Q3 | – | Sell |
-2,110
| Closed | -$221K | – | 175 |
|
|
2015
Q2 | $221K | Hold |
2,110
| – | – | 0.05% | 164 |
|
|
2015
Q1 | $218K | Sell |
2,110
-1,147
| -35% | -$116K | 0.05% | 170 |
|
|
2014
Q4 | $314K | Sell |
3,257
-1,957
| -38% | -$172K | 0.07% | 145 |
|
|
2014
Q3 | $415K | Sell |
5,214
-205
| -4% | -$16.2K | 0.1% | 126 |
|
|
2014
Q2 | $408K | Sell |
5,419
-685
| -11% | -$51.8K | 0.09% | 133 |
|
|
2014
Q1 | $457K | Buy |
6,104
+253
| +4% | +$17.9K | 0.11% | 124 |
|
|
2013
Q4 | $419K | Buy |
5,851
+32
| +0.5% | +$2.06K | 0.11% | 121 |
|
|
2013
Q3 | $330K | Sell |
5,819
-1,098
| -16% | -$65.4K | 0.09% | 124 |
|
|
2013
Q2 | $396K | Buy |
+6,917
| New | +$401K | 0.11% | 114 |
|
Other funds holding CVS
VCM
VPM
Foster & Motley's CVS Position: Q1 2026 in Review
Foster & Motley increased its CVS Health (CVS) stake by 3.1% in Q1 2026, buying an estimated $39.6K and bringing the position to 17,101 shares worth $1.23M. The position accounts for 0.06% of the portfolio, ranked #209.
Foster & Motley first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.77M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Foster & Motley held 17,101 shares of CVS Health worth $1.23M as of Q1 2026.
- Foster & Motley bought 514 CVS Health shares in Q1 2026, an estimated $39.6K.
- CVS Health made up 0.06% of Foster & Motley's portfolio in Q1 2026, its #209 holding.
- Foster & Motley first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
- Foster & Motley's CVS Health position peaked at $6.77M in Q4 2022.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.